Cargando…
Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451140/ https://www.ncbi.nlm.nih.gov/pubmed/30963130 http://dx.doi.org/10.5114/amsad.2019.83302 |
| _version_ | 1783409135518220288 |
|---|---|
| author | Patoulias, Dimitrios Ioannis |
| author_facet | Patoulias, Dimitrios Ioannis |
| author_sort | Patoulias, Dimitrios Ioannis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6451140 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64511402019-04-08 Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? Patoulias, Dimitrios Ioannis Arch Med Sci Atheroscler Dis Letter to the Editor Termedia Publishing House 2019-03-04 /pmc/articles/PMC6451140/ /pubmed/30963130 http://dx.doi.org/10.5114/amsad.2019.83302 Text en Copyright: © 2019 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
| spellingShingle | Letter to the Editor Patoulias, Dimitrios Ioannis Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| title | Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| title_full | Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| title_fullStr | Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| title_full_unstemmed | Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| title_short | Sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| title_sort | sodium glucose co-transporter 2 inhibitors mediated ketogenesis in patients with metabolic syndrome: clear benefit or anticipated fear? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451140/ https://www.ncbi.nlm.nih.gov/pubmed/30963130 http://dx.doi.org/10.5114/amsad.2019.83302 |
| work_keys_str_mv | AT patouliasdimitriosioannis sodiumglucosecotransporter2inhibitorsmediatedketogenesisinpatientswithmetabolicsyndromeclearbenefitoranticipatedfear |